Anti-CD14 antibody
5
(1 Review)
|
(13 Publications)
Goat Polyclonal CD14 antibody. Suitable for WB and reacts with Human samples. Cited in 13 publications. Immunogen corresponding to Synthetic Peptide within Human CD14 aa 50-100.
View Alternative Names
CD14, Monocyte differentiation antigen CD14, My23 antigen, Myeloid cell-specific leucine-rich glycoprotein
- WB
Supplier Data
Western blot - Anti-CD14 antibody (AB45870)
Primary incubation 1 hour at room temperature. Detected by chemiluminescence. RIPA buffer used.
All lanes:
Western blot - Anti-CD14 antibody (ab45870) at 2 µg/mL
Lane 1:
Human lymph node lysate at 35 µg
Lane 2:
Human lymph node lysate and immunizing peptide at 35 µg
Lane 3:
Human tonsil lysate at 35 µg
Lane 4:
Human tonsil lysate and Immunizing peptide at 35 µg
Predicted band size: 40 kDa
Observed band size: 55 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This glycoprotein plays a significant role in the innate immune system by recognizing pathogen-associated molecular patterns (PAMPs). It is part of a receptor complex where CD14 acts alongside LPS binding protein (LPS-R) TLR4 and MD-2 to facilitate pro-inflammatory signaling in response to microbial invasion. By binding to LPS CD14 initiates and amplifies the immune response leading to the production of cytokines and the recruitment of other immune cells to the site of infection.
Pathways
CD14 interacts with the toll-like receptor signaling pathway notably involving TLR4. Upon LPS detection CD14 assists in the activation of TLR4 triggering downstream signaling cascades such as NF-κB and MAPK pathways. These pathways result in the transcription of inflammatory cytokines and are essential for the host defense mechanism. The protein complex involving CD14 further interacts with adaptor proteins like MyD88 and TRIF facilitating signal propagation and the immune system's ability to respond to pathogens.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Cellular and molecular life sciences : CMLS 79:542 PubMed36203068
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomedical reports 17:82 PubMed36158321
2022
Applications
Unspecified application
Species
Unspecified reactive species
Endocrine 71:242-252 PubMed33010002
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncoimmunology 9:1773204 PubMed32923132
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and bioengineering 116:2652-2661 PubMed31180145
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and bioengineering 116:1269-1279 PubMed30684361
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 66:129-140 PubMed27858101
2016
Applications
IHC-P
Species
Human
Biomedical research (Tokyo, Japan) 36:143-53 PubMed25876665
2015
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 12:2169-74 PubMed25845433
2015
Applications
Unspecified application
Species
Unspecified reactive species
Science translational medicine 6:250ra112 PubMed25143362
2014
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com